Note: Medicinal Genomics's revenues are gauged from an analysis of company filings.
Medicinal Genomics's Income Statement (based on Industry Averages)
Medicinal Genomics P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Investor Activity
Medicinal Genomics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
April 7, 2021
0
N/A
$0 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Medicinal Genomics is developing and marketing.
Medicinal Genomics doesn't have any recent trademark applications, indicating Medicinal Genomics is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
GRIM REEFER Chemical treatment kits for removal of DNA
09/25/2019
CANNMED Organizing live and on-line exhibitions and conferences in the fields of medicine, clinical applications of cannabis, cannabis cultivation, cannabis growing, research lab safety, medical cannabis research and development, and cannabis all for educational purposes; Educational services, namely, developing, arranging, and conducting conferences and programs and providing courses of instruction in the fields of medicine, clinical applications of cannabis, cannabis cultivation, cannabis growing, research lab safety, medical cannabis research and development, and cannabis; Educational services, namely, conducting conferences, seminars, and workshops in the fields of medicine, clinical applications of cannabis, cannabis cultivation, cannabis growing, research lab safety, medical cannabis research and development, and cannabis and distribution of educational materials in connection therewith
08/29/2019
See all trademarks and details in the Full Report.
Market Share of Medicinal Genomics's Largest Competitors
A competitive analysis shows these companies are in the same general field as Medicinal Genomics, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Medicinal Genomics.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Medicinal Genomics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.
My Watch List
